Filing Flows › Cryo Cell International (CCEL) › Q4 FY25
Cryo Cell International (CCEL) Q4 FY25 earnings results (fourth quarter fiscal 2025)
10-K filed Feb 27, 2026
Cryo Cell International (CCEL) reported revenue of $7.8M for the fourth quarter fiscal 2025 (Q4 FY25), -2% from a year earlier and +0.2% from the quarter before. Operating margin was -50.6%, net loss $3.8M (48.7% of revenue).
Cryo Cell International, Q4 FY25: revenue $7.8M (-2% year over year), operating margin -50.6%, net loss $3.8M, operating cash flow $1.3M. The chart follows the revenue to costs, profit and cash.
| Q4 FY25 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.8M | +0.2% | -2% |
| Operating profit | −$4.0M | -309% | — |
| Net earnings | −$3.8M | -609% | — |
| Operating cash flow | $1.3M | -50% | -41% |
| Free cash flow | $1.2M | -51% | -44% |
What changed
Revenue was $7.8M in Q4 FY25, down 2% year over year and roughly flat from the previous quarter. Processing and Storage Fees was the largest line at 100% of revenue.
Operating costs exceeded revenue by $4.0M, an operating margin of -50.6%. Total costs grew 45% against a revenue fall of 2%. The fastest-growing cost line was Other operating costs (+2218%). The quarter ended with a net loss of $3.8M, after a profit of $749K the previous quarter.
Operating cash flow was $1.3M (down 41% year over year). Non-cash charges added back $243K of depreciation and amortization and $43K of share-based compensation. Working capital and other items added $4.8M. Capital expenditures of $67K left free cash flow of $1.2M.
Questions
What was Cryo Cell International's revenue in the fourth quarter fiscal 2025?
Cryo Cell International (CCEL) reported revenue of $7.8M for the fourth quarter fiscal 2025 (Q4 FY25), -2% from a year earlier and +0.2% from the quarter before.
Was Cryo Cell International profitable in the fourth quarter fiscal 2025?
Operating loss was $4.0M (-50.6% of revenue) and net loss $3.8M.